Golden
Rani Therapeutics

Rani Therapeutics

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

Rani Therapeutics is biotherapeutics company based in San Jose, California. It develops novel approaches for the oral delivery of peptides, proteins, and therapeutic antibodies that can normally only be delivered through injections. The approach and technology for Rani Therapeutics was developed at InCube Labs, a multidisciplinary R&D lab focused on developing medical innovations.

It's main product, Rani's 'robotic' pill is a device which navigates through the stomach and enters the small intestine. The capsule then goes through a transformation and aligns itself and injects the drug into the intestinal wall. Rani has identified several potential molecules to be used with the RaniPill:

  • Ocreotide - lowers levels of excess growth hormones for the treatment of acromegaly, a disorder characterized by enlargement of face, hands, and feet.
  • Basal Insulin - used in diabetes management as a way to regulate glucose levels in between meals.
  • GLP-1 - a class of drugs used in the treatment of Type II diabetes and obesity.
  • Parathyroid Hormone (PTH) - commonly used for the treatment of osteoporosis, PTH increases the concentration of calcium in the blood by acting upon the parathyroid hormone 1 & 2 receptor.
  • Human Growth Hormone (HGH) - a peptide hormone that stimulates growth, cell reproduction, and regeneration, and is used in the treatment of growth disorders and growth deficiency.
  • Human Interferon beta-1a - a cytokine or small protein in the interferon family used for the treatment of multiple sclerosis.
  • TNF-alpha (TNFa) Inhibitors - supresses response to tumor necrosis factor, part of the inflammatory response. Used to treat a number of inflammatory disorders including rheumatoid arthritis and Crohn's disease.
  • Interleukin Antibodies - various antibodies targeting specific interleukins for the treatment of various inflammatory diseases, such as rheumatoid arthritis, Chrohn's disease, and psoriasis.
  • PCSK9 - a treatment for cardiovascular disease that is often used with other therapies like statins to lower low-density lipoprotein cholesterol (LDL-C) for patients with hyperlipidemia.
  • Factor VIII, Factor IX, Factor X - treatments of blood clotting disorders, including Hemophilia A and B.

Timeline

People

Name
Role
Related Golden topics

Alan Huang

Investor

Angela Murch

Vice President

Arvinder Dhalla

Senior Director of Strategy & Program Management

Betsy Gutierrez

Associate VP of Quality Assurance

Dr. Rudi Ruffy

Medical Director

John Parsons

Investor

Larry Albukerk

Investor

Mir Hashim

Chief Scientific Officer

Mir Imran

Chairman & CEO

Ruben Azrak

Investor

Stephanie McGrory

VP of Business Development

Svai Sanford

CFO

Talat Imran

Investor

Wilfredo Ortiz

Associate VP of Manufacturing

Further reading

Title
Author
Link
Type

Shire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor Therapy

Shire Pharmaceuticals Group

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References